• June 16-19, 2025
  • Boston Convention & Exhibition Center

Sessions

Loading

InVivo Biosystems

Wednesday, June 05, 2024
Company Presentation
CNS/Neurological
Company Presentation Theater 4
In Vivo Biosystems enables drug discovery and development in neurological, metabolic, and rare monogenic disease indications with our premiere proprietary platform, RapidGen. RapidGen leverages -omic data and multiplexed CRISPR to speed target identification & multimodal therapeutics screening on highly relevant behavioral and molecular endpoints in vivo.
InVivo Biosystems
Company Website: https://invivobiosystems.com/
Lead Product in Development: IVB-269
Number Of Unlicensed Products (For Which You Are Seeking Partners): 2

Company HQ City

Eugene

Company HQ State

Oregon

Company HQ Country

United States

CEO/Top Company Official

Kat McCromick

Development Phase of Primary Product

Pre-Clinical
Primary Speaker
Kat McCormick
CEO
InVivo Biosystems
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS